NANOBIOTIX appoints Arnd Christ as Chief Financial Officer

NANOBIOTIX, a French biotechnology company listed on Euronext and Nasdaq, announces the appointment of Arnd Christ as Chief Financial Officer. Mr. Christ, with over twenty years of experience, previously served as Chief Financial Officer at Immatics NV. He succeeds Bart Van Rhijn, who contributed to the company's financial strengthening over five years.

Laurent Lévy, president of Nanobiotix, emphasizes the importance of this appointment at a key moment in the company's evolution towards diversified platforms. Christ's contribution is seen as crucial for supporting continued growth and seizing new opportunities in the field of biotechnology.